HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist
  • 8.350
  • +0.820+10.89%
Trading Jul 17 13:15 CST
3.33BMarket Cap-7892P/E (TTM)

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
36.78%-380.16M
----
-10.21%-601.35M
----
-14.46%-545.64M
----
-55.57%-476.69M
---306.41M
Profit adjustment
Attributable subsidiary (profit) loss
-32.11%10.03M
----
3,574.13%14.77M
----
562.07%402K
----
---87K
----
Impairment and provisions:
184.97%13.7M
--0
-2.30%4.81M
--0
19.00%4.92M
--0
19.57%4.14M
--3.46M
-Impairmen of inventory (reversal)
178.18%9.42M
----
87.44%3.39M
----
-31.14%1.81M
----
-12.82%2.62M
--3.01M
-Impairment of trade receivables (reversal)
201.13%4.28M
----
-54.35%1.42M
----
106.02%3.12M
----
236.75%1.51M
--449K
Revaluation surplus:
75.80%-5.03M
--0
-83.57%-20.78M
--0
48.86%-11.32M
--0
-2,800.79%-22.13M
---763K
-Derivative financial instruments fair value (increase)
----
----
--2.41M
----
----
----
----
----
-Other fair value changes
78.32%-5.03M
----
-104.89%-23.19M
----
48.86%-11.32M
----
-2,800.79%-22.13M
---763K
Asset sale loss (gain):
92.77%-1.83M
--0
-2,404.45%-25.35M
--0
50.95%-1.01M
--0
-1,922.55%-2.06M
---102K
-Loss (gain) from sale of subsidiary company
----
----
---25.43M
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
-2,334.15%-1.83M
----
121.30%82K
----
-132.06%-385K
----
4,904.17%1.2M
--24K
-Loss (gain) from selling other assets
----
----
----
----
80.79%-627K
----
-2,490.48%-3.26M
---126K
Depreciation and amortization:
4.79%182.45M
--0
35.91%174.1M
--0
195.38%128.1M
--0
52.45%43.37M
--28.45M
-Depreciation
2.18%174.76M
----
35.23%171.03M
----
197.65%126.48M
----
53.49%42.49M
--27.69M
-Amortization of intangible assets
150.67%7.68M
----
89.67%3.07M
----
84.90%1.62M
----
14.85%874K
--761K
Financial expense
77.85%99.84M
----
42.39%56.14M
----
74.93%39.43M
----
187.21%22.54M
--7.85M
Exchange Loss (gain)
57.64%-7.02M
----
-1,032.88%-16.57M
----
-73.05%1.78M
----
778.68%6.59M
---971K
Special items
38.74%21.25M
----
-44.82%15.31M
----
-87.84%27.75M
----
49.79%228.27M
--152.39M
Operating profit before the change of operating capital
83.26%-66.77M
--0
-12.18%-398.91M
--0
-81.36%-355.6M
--0
-68.89%-196.08M
---116.1M
Change of operating capital
Inventory (increase) decrease
159.28%3.79M
----
78.64%-6.4M
----
-466.84%-29.96M
----
-13,453.85%-5.29M
---39K
Accounts receivable (increase)decrease
-749.44%-39.02M
----
87.19%-4.59M
----
-10.75%-35.86M
----
-1,036.18%-32.38M
---2.85M
Accounts payable increase (decrease)
-100.02%-21K
----
59.31%88.27M
----
198.79%55.41M
----
264.75%18.54M
--5.08M
prepayments (increase)decrease
-48.37%16.36M
----
363.41%31.69M
----
25.33%-12.03M
----
8.24%-16.11M
---17.56M
Cash  from business operations
74.94%-76.01M
84.19%-17.57M
17.09%-303.27M
28.98%-111.16M
-62.34%-365.78M
---156.52M
-506.43%-225.31M
---37.15M
Other taxs
20.40%-640K
----
---804K
----
----
----
----
----
Special items of business
177.09%9.65M
----
-201.96%-12.51M
----
104.65%12.27M
----
-93.64%6M
--94.31M
Net cash from operations
74.73%-76.65M
84.19%-17.57M
17.09%-303.27M
28.98%-111.16M
-62.34%-365.78M
---156.52M
-506.43%-225.31M
---37.15M
Cash flow from investment activities
Sale of fixed assets
1,511.01%26.34M
172.94%232K
-65.63%1.64M
-93.06%85K
10,471.11%4.76M
--1.22M
-71.15%45K
--156K
Purchase of fixed assets
47.30%-126.62M
33.74%-90.24M
-20.94%-240.27M
-10.65%-136.2M
32.98%-198.67M
---123.09M
-93.32%-296.42M
---153.34M
Sale of subsidiaries
----
----
---6.86M
---6.86M
----
----
----
----
Recovery of cash from investments
----
----
-84.38%101.46M
-39.60%100M
-53.36%649.78M
--165.56M
2,254.09%1.39B
--59.18M
Cash on investment
----
----
98.20%-9.71M
----
57.98%-540M
---360M
-314.52%-1.29B
---310M
Net cash from investment operations
34.77%-100.28M
-109.48%-90.01M
-82.74%-153.74M
86.42%-42.97M
55.29%-84.13M
---316.31M
53.42%-188.18M
---404M
Net cash before financing
61.29%-176.92M
30.20%-107.58M
-1.58%-457M
67.40%-154.13M
-8.81%-449.91M
---472.83M
6.27%-413.49M
---441.15M
Cash flow from financing activities
New borrowing
52.63%319.91M
98.15%113.37M
--209.6M
--57.22M
----
----
----
----
Refund
-402.96%-150.82M
-1,053.92%-57.8M
---29.99M
86.52%-5.01M
----
---37.15M
-688.55%-72.13M
---9.15M
Interest paid - financing
-41.66%-24.08M
-173.72%-9.98M
-121.83%-17M
3.49%-3.65M
-91.24%-7.66M
---3.78M
-474.07%-4.01M
---698K
Absorb investment income
----
----
67.52%521.06M
----
216.23%311.04M
--291.6M
31,629.03%98.36M
--310K
Issuance expenses and redemption of securities expenses
53.08%-10.77M
73.25%-2.57M
14.36%-22.96M
---9.6M
---26.81M
----
----
----
Other items of the financing business
-134.05%-172.05M
20.33%-21.51M
-28.67%-73.51M
-402.85%-27M
-106.75%-57.13M
---5.37M
69.55%846.22M
--499.09M
Net cash from financing operations
-106.44%-37.82M
79.86%21.51M
167.59%587.2M
-95.12%11.96M
-74.73%219.44M
--245.3M
77.39%868.44M
--489.56M
Effect of rate
-75.65%3.47M
31.72%9.95M
3,847.63%14.24M
164.76%7.55M
90.59%-380K
--2.85M
-349.78%-4.04M
---898K
Net Cash
-264.94%-214.74M
39.46%-86.07M
156.49%130.2M
37.52%-142.17M
-150.66%-230.47M
---227.53M
839.88%454.95M
--48.41M
Begining period cash
30.97%610.88M
30.97%610.88M
-33.11%466.45M
-33.11%466.45M
183.01%697.29M
--697.29M
23.89%246.38M
--198.88M
Cash at the end
-34.59%399.61M
61.16%534.76M
30.97%610.88M
-29.79%331.83M
-33.11%466.45M
--472.62M
183.01%697.29M
--246.38M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
KPMG
--
KPMG
--
KPMG
--
KPMG
KPMG
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 36.78%-380.16M-----10.21%-601.35M-----14.46%-545.64M-----55.57%-476.69M---306.41M
Profit adjustment
Attributable subsidiary (profit) loss -32.11%10.03M----3,574.13%14.77M----562.07%402K-------87K----
Impairment and provisions: 184.97%13.7M--0-2.30%4.81M--019.00%4.92M--019.57%4.14M--3.46M
-Impairmen of inventory (reversal) 178.18%9.42M----87.44%3.39M-----31.14%1.81M-----12.82%2.62M--3.01M
-Impairment of trade receivables (reversal) 201.13%4.28M-----54.35%1.42M----106.02%3.12M----236.75%1.51M--449K
Revaluation surplus: 75.80%-5.03M--0-83.57%-20.78M--048.86%-11.32M--0-2,800.79%-22.13M---763K
-Derivative financial instruments fair value (increase) ----------2.41M--------------------
-Other fair value changes 78.32%-5.03M-----104.89%-23.19M----48.86%-11.32M-----2,800.79%-22.13M---763K
Asset sale loss (gain): 92.77%-1.83M--0-2,404.45%-25.35M--050.95%-1.01M--0-1,922.55%-2.06M---102K
-Loss (gain) from sale of subsidiary company -----------25.43M--------------------
-Loss (gain) on sale of property, machinery and equipment -2,334.15%-1.83M----121.30%82K-----132.06%-385K----4,904.17%1.2M--24K
-Loss (gain) from selling other assets ----------------80.79%-627K-----2,490.48%-3.26M---126K
Depreciation and amortization: 4.79%182.45M--035.91%174.1M--0195.38%128.1M--052.45%43.37M--28.45M
-Depreciation 2.18%174.76M----35.23%171.03M----197.65%126.48M----53.49%42.49M--27.69M
-Amortization of intangible assets 150.67%7.68M----89.67%3.07M----84.90%1.62M----14.85%874K--761K
Financial expense 77.85%99.84M----42.39%56.14M----74.93%39.43M----187.21%22.54M--7.85M
Exchange Loss (gain) 57.64%-7.02M-----1,032.88%-16.57M-----73.05%1.78M----778.68%6.59M---971K
Special items 38.74%21.25M-----44.82%15.31M-----87.84%27.75M----49.79%228.27M--152.39M
Operating profit before the change of operating capital 83.26%-66.77M--0-12.18%-398.91M--0-81.36%-355.6M--0-68.89%-196.08M---116.1M
Change of operating capital
Inventory (increase) decrease 159.28%3.79M----78.64%-6.4M-----466.84%-29.96M-----13,453.85%-5.29M---39K
Accounts receivable (increase)decrease -749.44%-39.02M----87.19%-4.59M-----10.75%-35.86M-----1,036.18%-32.38M---2.85M
Accounts payable increase (decrease) -100.02%-21K----59.31%88.27M----198.79%55.41M----264.75%18.54M--5.08M
prepayments (increase)decrease -48.37%16.36M----363.41%31.69M----25.33%-12.03M----8.24%-16.11M---17.56M
Cash  from business operations 74.94%-76.01M84.19%-17.57M17.09%-303.27M28.98%-111.16M-62.34%-365.78M---156.52M-506.43%-225.31M---37.15M
Other taxs 20.40%-640K-------804K--------------------
Special items of business 177.09%9.65M-----201.96%-12.51M----104.65%12.27M-----93.64%6M--94.31M
Net cash from operations 74.73%-76.65M84.19%-17.57M17.09%-303.27M28.98%-111.16M-62.34%-365.78M---156.52M-506.43%-225.31M---37.15M
Cash flow from investment activities
Sale of fixed assets 1,511.01%26.34M172.94%232K-65.63%1.64M-93.06%85K10,471.11%4.76M--1.22M-71.15%45K--156K
Purchase of fixed assets 47.30%-126.62M33.74%-90.24M-20.94%-240.27M-10.65%-136.2M32.98%-198.67M---123.09M-93.32%-296.42M---153.34M
Sale of subsidiaries -----------6.86M---6.86M----------------
Recovery of cash from investments ---------84.38%101.46M-39.60%100M-53.36%649.78M--165.56M2,254.09%1.39B--59.18M
Cash on investment --------98.20%-9.71M----57.98%-540M---360M-314.52%-1.29B---310M
Net cash from investment operations 34.77%-100.28M-109.48%-90.01M-82.74%-153.74M86.42%-42.97M55.29%-84.13M---316.31M53.42%-188.18M---404M
Net cash before financing 61.29%-176.92M30.20%-107.58M-1.58%-457M67.40%-154.13M-8.81%-449.91M---472.83M6.27%-413.49M---441.15M
Cash flow from financing activities
New borrowing 52.63%319.91M98.15%113.37M--209.6M--57.22M----------------
Refund -402.96%-150.82M-1,053.92%-57.8M---29.99M86.52%-5.01M-------37.15M-688.55%-72.13M---9.15M
Interest paid - financing -41.66%-24.08M-173.72%-9.98M-121.83%-17M3.49%-3.65M-91.24%-7.66M---3.78M-474.07%-4.01M---698K
Absorb investment income --------67.52%521.06M----216.23%311.04M--291.6M31,629.03%98.36M--310K
Issuance expenses and redemption of securities expenses 53.08%-10.77M73.25%-2.57M14.36%-22.96M---9.6M---26.81M------------
Other items of the financing business -134.05%-172.05M20.33%-21.51M-28.67%-73.51M-402.85%-27M-106.75%-57.13M---5.37M69.55%846.22M--499.09M
Net cash from financing operations -106.44%-37.82M79.86%21.51M167.59%587.2M-95.12%11.96M-74.73%219.44M--245.3M77.39%868.44M--489.56M
Effect of rate -75.65%3.47M31.72%9.95M3,847.63%14.24M164.76%7.55M90.59%-380K--2.85M-349.78%-4.04M---898K
Net Cash -264.94%-214.74M39.46%-86.07M156.49%130.2M37.52%-142.17M-150.66%-230.47M---227.53M839.88%454.95M--48.41M
Begining period cash 30.97%610.88M30.97%610.88M-33.11%466.45M-33.11%466.45M183.01%697.29M--697.29M23.89%246.38M--198.88M
Cash at the end -34.59%399.61M61.16%534.76M30.97%610.88M-29.79%331.83M-33.11%466.45M--472.62M183.01%697.29M--246.38M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor KPMG--KPMG--KPMG--KPMGKPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg